Clinical Trial Update: Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the immunogenicity and safety of concomitant and non-concomitant administration of RotaTeq (V260) and Inactivated Poliomyelitis Vaccine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Inactivated Poliomyelitis Vaccine (inactivated poliovirus vaccine)
• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9 | Phase 3 | Status: COMPLETED | Results posted: 2023-02-17